enGene to host KOL webinar on high — risk NMIBC treatment decisions and LEGEND trial data
enGene will host a KOL webinar on Oct. 15, 2026 at 10:00 a.m. ET. * Agenda includes preclinical data supporting a polidocanol surfactant bladder rinse before intravesical detalimogene for BCG-unresponsive, high-risk NMIBC with CIS. Community KOLs David J. Cahn, MD, Suzanne B. Merrill, MD, FACS will discuss real-world t